| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
Division of Toxicology and Cancer Risk Factors, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany
Tobacco use is causally associated with cancers of the lung, larynx, mouth, esophagus, kidneys, urinary tract, and possibly, breast. Major classes of carcinogens present in tobacco and tobacco smoke are converted into DNA-reactive metabolites by cytochrome P450 (CYP)-related enzymes, several of which display genetic polymorphism. Individual susceptibility to cancer is likely to be modified by the genotype for enzymes involved in the activation or detoxification of carcinogens in tobacco and repair of DNA damage. We summarize here the results of case-control studies published since 1990 on the effects of genetic variants of CYP1A1, 1A2, 1B1, 2A6, 2D6, 2E1, 2C9, 2C19, 17, and 19 alone or in combination with detoxifying enzymes as modifiers of the risk for tobacco-related cancers. The results of studies on gene-gene interactions and the dependence of smoking-related DNA adducts on genotype were also analyzed. Some CYP variants were associated with increased risks for cancers of the lung, esophagus, and head and neck. The risk was often increased in individuals who also had GSTM1 deficiency. For breast cancer in women, a few studies suggested an association with CYPs related to metabolism of tobacco carcinogens and steroidal hormones.
The overall effects of common CYP polymorphisms were found to be moderate in terms of penetrance and relative risk, with odds ratios ranging from 2 to 10. Some CYP1A1/GSTM1 0/0 genotype combinations seem to predispose the lung, esophagus, and oral cavity of smokers to an even higher risk for cancer or DNA damage, requiring, however, confirmation. Future strategies in molecular cancer epidemiology for identifying such susceptible individuals are discussed with emphasis on well-designed larger studies.
This article has been cited by other articles:
|
|
 |
|
  S. S. Hecht, P. W. Villalta, and J.B. Hochalter Analysis of phenanthrene diol epoxide mercapturic acid detoxification products in human urine: relevance to molecular epidemiology studies of glutathione S-transferase polymorphisms Carcinogenesis, May 1, 2008; 29(5): 937 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. McKay, M. Hashibe, R. J. Hung, J. Wakefield, V. Gaborieau, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, et al. Sequence Variants of NAT1 and NAT2 and Other Xenometabolic Genes and Risk of Lung and Aerodigestive Tract Cancers in Central Europe Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Yoo, M. W. Lee, Y. C. Kim, C.-H. Yun, and D.-H. Kim Mechanism-Based Inactivation of Cytochrome P450 2A6 by Decursinol Angelate Isolated from Angelica Gigas Drug Metab. Dispos., October 1, 2007; 35(10): 1759 - 1765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vineis, S. Anttila, S. Benhamou, M. Spinola, A. Hirvonen, C. Kiyohara, S. J. Garte, R. Puntoni, A. Rannug, R. C. Strange, et al. Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis Carcinogenesis, September 1, 2007; 28(9): 1902 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wu, Y. Hu, C. Chen, F. Yang, Z. Li, Z. Fang, L. Wang, and D. Chen Passive Smoking, Metabolic Gene Polymorphisms, and Infant Birth Weight in a Prospective Cohort Study of Chinese Women Am. J. Epidemiol., August 1, 2007; 166(3): 313 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kury, B. Buecher, S. Robiou-du-Pont, C. Scoul, V. Sebille, H. Colman, C. Le Houerou, T. Le Neel, J. Bourdon, R. Faroux, et al. Combinations of Cytochrome P450 Gene Polymorphisms Enhancing the Risk for Sporadic Colorectal Cancer Related to Red Meat Consumption Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1460 - 1467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Anantharaman, P. M. Chaubal, S. Kannan, R. A. Bhisey, and M. B. Mahimkar Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator Carcinogenesis, July 1, 2007; 28(7): 1455 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Amal Al Omari and D. J. Murry Pharmacogenetics of the Cytochrome P450 Enzyme System: Review of Current Knowledge and Clinical Significance Journal of Pharmacy Practice, June 1, 2007; 20(3): 206 - 218. [Abstract] [PDF]
|
|
|
|
|
|
F. Gemignani, S. Landi, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, L. Foretova, V. Janout, et al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes Carcinogenesis, June 1, 2007; 28(6): 1287 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Schwartz, G. M. Prysak, C. H. Bock, and M. L. Cote The molecular epidemiology of lung cancer Carcinogenesis, March 1, 2007; 28(3): 507 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Agudo, N. Sala, G. Pera, G. Capella, A. Berenguer, N. Garcia, D. Palli, H. Boeing, G. Del Giudice, C. Saieva, et al. Polymorphisms in Metabolic Genes Related to Tobacco Smoke and the Risk of Gastric Cancer in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2427 - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kohno, T. Sakiyama, H. Kunitoh, K. Goto, Y. Nishiwaki, D. Saito, H. Hirose, T. Eguchi, N. Yanagitani, R. Saito, et al. Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk Carcinogenesis, December 1, 2006; 27(12): 2448 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, A. Yoder, M. Chen, Z.-z. Li, C. Le, R. Dayton, J. Jensen, and D. K. Hatsukami Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1805 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-i. Nitadori, M. Inoue, M. Iwasaki, T. Otani, S. Sasazuki, K. Nagai, S. Tsugane, and the JPHC Study Group Association Between Lung Cancer Incidence and Family History of Lung Cancer: Data From a Large-Scale Population-Based Cohort Study, the JPHC Study. Chest, October 1, 2006; 130(4): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Nagata, T. Mizoue, K. Tanaka, I. Tsuji, K. Wakai, M. Inoue, S. Tsugane, and Research Group for the Development and Evaluation Tobacco Smoking and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiological Evidence among the Japanese Population Jpn. J. Clin. Oncol., June 1, 2006; 36(6): 387 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pisani, P. Srivatanakul, J. Randerson-Moor, S. Vipasrinimit, S. Lalitwongsa, P. Unpunyo, S. Bashir, and D. T. Bishop GSTM1 and CYP1A1 Polymorphisms, Tobacco, Air Pollution, and Lung Cancer: A Study in Rural Thailand. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 667 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, M. Chen, A. Yoder, J. Jensen, D. Hatsukami, C. Le, and S. G. Carmella Longitudinal Study of Urinary Phenanthrene Metabolite Ratios: Effect of Smoking on the Diol Epoxide Pathway Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2969 - 2974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.S. Wenzlaff, M.L. Cote, C.H. Bock, S.J. Land, S.K. Santer, D.R. Schwartz, and A.G. Schwartz CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study Carcinogenesis, December 1, 2005; 26(12): 2207 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Arlt 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence Mutagenesis, November 1, 2005; 20(6): 399 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Garavello, E. Negri, R. Talamini, F. Levi, P. Zambon, L. Dal Maso, C. Bosetti, S. Franceschi, and C. La Vecchia Family History of Cancer, Its Combination with Smoking and Drinking, and Risk of Squamous Cell Carcinoma of the Esophagus Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1390 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hou, N. Chatterjee, W.-Y. Huang, A. Baccarelli, S. Yadavalli, M. Yeager, R. S. Bresalier, S. J. Chanock, N. E. Caporaso, B.-T. Ji, et al. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma Carcinogenesis, June 1, 2005; 26(6): 1122 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kisselev, W.-H. Schunck, I. Roots, and D. Schwarz Association of CYP1A1 Polymorphisms with Differential Metabolic Activation of 17{beta}-Estradiol and Estrone Cancer Res., April 1, 2005; 65(7): 2972 - 2978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Olliver, L. J. Hardie, Y. Gong, S. Dexter, D. Chalmers, K. M. Harris, and C. P. Wild Risk Factors, DNA Damage, and Disease Progression in Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 620 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Georgiadis, J. Topinka, D. Vlachodimitropoulos, M. Stoikidou, M. Gioka, G. Stephanou, H. Autrup, N. A. Demopoulos, K. Katsouyanni, R. Sram, et al. Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations Carcinogenesis, January 1, 2005; 26(1): 93 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pavanello, A. Pulliero, E. Siwinska, D. Mielzynska, and E. Clonfero Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers Carcinogenesis, January 1, 2005; 26(1): 169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Carmella, M. Chen, H. Yagi, D. M. Jerina, and S. S. Hecht Analysis of Phenanthrols in Human Urine by Gas Chromatography-Mass Spectrometry: Potential Use in Carcinogen Metabolite Phenotyping Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2167 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peluso, M. Neri, G. Margarino, C. Mereu, A. Munnia, M. Ceppi, M. Buratti, R. Felletti, F. Stea, R. Quaglia, et al. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms Carcinogenesis, December 1, 2004; 25(12): 2459 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Suryanarayana, M. Deenadayal, and L. Singh Association of CYP1A1 gene polymorphism with recurrent pregnancy loss in the South Indian population Hum. Reprod., November 1, 2004; 19(11): 2648 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, L.-E Wang, R. M. Chamberlain, C. I. Amos, M. R. Spitz, and Q. Wei p73 G4C14-to-A4T14 Polymorphism and Risk of Lung Cancer Cancer Res., October 1, 2004; 64(19): 6863 - 6866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lodovici, C. Luceri, F. Guglielmi, C. Bacci, V. Akpan, M. L. Fonnesu, V. Boddi, and P. Dolara Benzo(a)pyrene Diolepoxide (BPDE)-DNA Adduct Levels in Leukocytes of Smokers in Relation to Polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1342 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liang, X. Miao, Y. Zhou, W. Tan, and D. Lin A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking Carcinogenesis, May 1, 2004; 25(5): 773 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Campa, S. Zienolddiny, V. Maggini, V. Skaug, A. Haugen, and F. Canzian Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer Carcinogenesis, February 1, 2004; 25(2): 229 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Paolini, P. Perocco, D. Canistro, L. Valgimigli, G. F. Pedulli, R. Iori, C. D. Croce, G. Cantelli-Forti, M. S. Legator, and S. Z. Abdel-Rahman Induction of cytochrome P450, generation of oxidative stress and in vitro cell-transforming and DNA-damaging activities by glucoraphanin, the bioprecursor of the chemopreventive agent sulforaphane found in broccoli Carcinogenesis, January 1, 2004; 25(1): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, M. Chen, H. Yagi, D. M. Jerina, and S. G. Carmella r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in Human Urine: A Potential Biomarker for Assessing Polycyclic Aromatic Hydrocarbon Metabolic Activation Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1501 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Paz-Elizur, M. Krupsky, S. Blumenstein, D. Elinger, E. Schechtman, and Z. Livneh DNA Repair Activity for Oxidative Damage and Risk of Lung Cancer J Natl Cancer Inst, September 3, 2003; 95(17): 1312 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Speina, M. Zielinska, A. Barbin, D. Gackowski, J. Kowalewski, M. A. Graziewicz, J. A. Siedlecki, R. Olinski, and B. Tudek Decreased Repair Activities of 1,N6-Ethenoadenine and 3,N4-Ethenocytosine in Lung Adenocarcinoma Patients Cancer Res., August 1, 2003; 63(15): 4351 - 4357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, P. Boffetta, J. Brockmoller, D. Butkiewicz, I. Cascorbi, M. L. Clapper, S. Garte, A. Haugen, A. Hirvonen, S. Anttila, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis Carcinogenesis, May 1, 2003; 24(5): 875 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Neuhouser, R. E. Patterson, M. D. Thornquist, G. S. Omenn, I. B. King, and G. E. Goodman Fruits and Vegetables Are Associated with Lower Lung Cancer Risk Only in the Placebo Arm of the {beta}-Carotene and Retinol Efficacy Trial (CARET) Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 350 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yanagitani, T. Kohno, J.-G. Kim, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota Identification of D19S246 as a Novel Lung Adenocarcinoma Susceptibility Locus by Genome Survey with 10-cM Resolution Microsatellite Markers Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hukkanen, T. Vaisanen, A. Lassila, R. Piipari, S. Anttila, O. Pelkonen, H. Raunio, and J. Hakkola Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in Human Lung-Derived Cells J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Liu, R. M. Russell, and X.-D. Wang Exposing Ferrets to Cigarette Smoke and a Pharmacological Dose of {beta}-Carotene Supplementation Enhance In Vitro Retinoic Acid Catabolism in Lungs via Induction of Cytochrome P450 Enzymes J. Nutr., January 1, 2003; 133(1): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Caporaso Why Have We Failed to Find the Low Penetrance Genetic Constituents of Common Cancers? Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1544 - 1549. [Full Text] [PDF]
|
|
|
|
|
|
K. Alexandrov, I. Cascorbi, M. Rojas, G. Bouvier, E. Kriek, and H. Bartsch CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation Carcinogenesis, December 1, 2002; 23(12): 1969 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Terry and T. E. Rohan Cigarette Smoking and the Risk of Breast Cancer in Women: A Review of the Literature Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 953 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sunaga, T. Kohno, N. Yanagitani, H. Sugimura, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota Contribution of the NQO1 and GSTT1 Polymorphisms to Lung Adenocarcinoma Susceptibility Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 730 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hamajima, T. Saito, K. Matsuo, and K. Tajima Competitive Amplification and Unspecific Amplification in Polymerase Chain Reaction with Confronting Two-Pair Primers J. Mol. Diagn., May 1, 2002; 4(2): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Krajinovic, D. Labuda, G. Mathonnet, M. Labuda, A. Moghrabi, J. Champagne, and D. Sinnett Polymorphisms in Genes Encoding Drugs and Xenobiotic Metabolizing Enzymes, DNA Repair Enzymes, and Response to Treatment of Childhood Acute Lymphoblastic Leukemia Clin. Cancer Res., March 1, 2002; 8(3): 802 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Duell, E. A. Holly, P. M. Bracci, M. Liu, J. K. Wiencke, and K. T. Kelsey A Population-Based, Case-Control Study of Polymorphisms in Carcinogen-Metabolizing Genes, Smoking, and Pancreatic Adenocarcinoma Risk J Natl Cancer Inst, February 20, 2002; 94(4): 297 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, B. Zuckerman, C. Pearson, G. Kaufman, C. Chen, G. Wang, T. Niu, P. H. Wise, H. Bauchner, and X. Xu Maternal Cigarette Smoking, Metabolic Gene Polymorphism, and Infant Birth Weight JAMA, January 9, 2002; 287(2): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, S. W. Thurston, L. L. Xu, D. P. Miller, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Genetic Polymorphisms in N-acetyltransferase-2 and Microsomal Epoxide Hydrolase, Cumulative Cigarette Smoking, and Lung Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 15 - 21. [Abstract] [Full Text]
|
|
|
|
|
|
S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al. Metabolic Gene Polymorphism Frequencies in Control Populations Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1239 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Garte, P. Boffetta, N. Caporaso, and P. Vineis Metabolic Gene Allele Nomenclature Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1305 - 1306. [Full Text] [PDF]
|
|
|
|
|
|
P. Xiong, M. L. Bondy, D. Li, H. Shen, L.-E Wang, S. E. Singletary, M. R. Spitz, and Q. Wei Sensitivity to Benzo(a)pyrene Diol-Epoxide Associated with Risk of Breast Cancer in Young Women and Modulation by Glutathione S-Transferase Polymorphisms: A Case-Control Study Cancer Res., December 1, 2001; 61(23): 8465 - 8469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cauchi, I. Stucker, C. Solas, P. Laurent-Puig, S. Cenee, D. Hemon, M. Jacquet, P. Kremers, P. Beaune, and L. Massaad-Massade Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer Carcinogenesis, November 1, 2001; 22(11): 1819 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. J. Smith, P. A. Harper, J. M. Y. Wong, M. S. M. Lam, K. R. Reid, D. Petsikas, and T. E. Massey Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 839 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Paolini, S. Z. Abdel-Rahman, G. Cantelli-Forti, and M. S. Legator Chemoprevention or Antichemo- prevention? A Salutary Warning From the {beta}-Carotene Experience J Natl Cancer Inst, July 18, 2001; 93(14): 1110 - 1111. [Full Text] [PDF]
|
|
|
|
|
|
M. Rojas, R. Godschalk, K. Alexandrov, I. Cascorbi, E. Kriek, J. Ostertag, F.-J. Van Schooten, and H. Bartsch Myeloperoxidase - 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients Carcinogenesis, July 1, 2001; 22(7): 1015 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
